Experiencia en nefrectomía: serie de casos de cuatro años
| Contribuinte(s) |
Salgado Tovar, Javier Mauricio |
|---|---|
| Data(s) |
20/01/2014
31/12/1969
|
| Resumo |
Introducción: Las indicaciones por las cuales un paciente requiere una nefrectomía son múltiples: las neoplasias, la hidronefrosis y la exclusión funcional son las principales. En manos expertas la nefrectomía es un procedimiento seguro, especialmente porque en la actualidad el abordaje por excelencia es realizar una técnica mínimamente invasiva con conservación de nefronas. Se presenta el análisis de la experiencia en Mederi, Hospital Universitario Mayor en esta intervención. Metodología: Se realizó una serie de casos de pacientes llevados a nefrectomía entre mayo de 2008 y mayo de 2012. Se incluyeron la totalidad de los casos. Resultados: Se analizaron 72 registros, 49 mujeres y 25 hombres; 13 de ellas fueron laparoscópicas. La edad promedio fue de 58,6 años. El tiempo medio operatorio fue 169,23 minutos (118-220 minutos). El sangrado operatorio promedio fue de 680,63 ml (IC95%: 2,83-1358 ml). El tiempo de hospitalización promedio fue de 4,88 días IC95%. La mayoría de los pacientes se distribuyeron en estadios medios de la enfermedad tumoral, con poco compromiso ganglionar y metástasis; el diagnóstico histológico y estadio dominante fueron el carcinoma de células renales grado 3 de Fuhrman respectivamente. Se reportan 13 casos de compromiso de la capsula de Gerota y 11 con compromiso del hilio. Discusión: La experiencia en nefrectomía de la institución es muy positiva por el bajo número de mortalidad y complicaciones. En cuanto a la técnica, es importante promover la técnica laparoscópica Introduction: The indications for a patient to require a nephrectomy are multiples, neoplasms, hydronephrosis and functional exclusion are the main causes. In experienced hands nephrectomy is a safe procedure, especially because nowadays the main approach is to perform a minimally invasive technique with nephron sparing. Analysis of the experience in Mederi is shown in this study. Methods A case series of patients who underwent nephrectomy between May 2008 and May 2012 was performed. All cases were included. Results 72 records, 49 women and 25 men were analyzed, 13 of which were laparoscopic. The average age was 58.6 years. The average operative time was 169.23 minutes (118- 220minutes). The mean operative blood loss was 680.63 ml. The mean hospital stay was 4.88 days, most patients were distributed in the middle stages of tumor disease, with little nodal involvement and metastasis, histological diagnosis and were the dominant stage renal cell carcinoma Fuhrman stage 3 respectively, 13 cases of Gerota 's capsule commitment and 11 cases with renal hilum commitment. The concordance between the imaging diagnosis (clinical) and intraoperative finding was moderate (κ0.46). Discussion Nephrectomy experience of the institution is very positive because of the low number of complications and mortality. As for the technique, it is important to promote the laparoscopic one. |
| Formato |
application/pdf |
| Identificador | |
| Idioma(s) |
spa |
| Publicador |
Facultad de Medicina |
| Direitos |
info:eu-repo/semantics/embargoedAccess |
| Fonte |
reponame:Repositorio Institucional EdocUR instname:Universidad del Rosario ET Bell, Tumors of the kidney Ed. Publishers Philadelphia 1950. Campbell NA Wright. Endotoxin and acute renal failure associated with obstructive jaundice. British medical journal 4(5733): 472–474. 1970 Schulam et al. Cost of cancer care. American society of clinical oncology. Vol. 25, No. 2, 180-186, 2007 Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. Cancer J Clin; 614: 212–36. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21685461 Landis Sara, Murray T et al. Cancer statistics, 1999. A cancer journal for clinicians. Vol 4 Issue 1. Pag 8-31 Yossepowitch, Houston R, Thompson, Russo et al, Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. The journal of urology Vol 179 issue 6. 2008 Carrizosa y Godley, Epidemiology and screening of renal cell carcinoma PMPH-USA, 2009 Jemal A Siegel R Ward et al, Cancer statistics Vol 59 Issue 4 225-249 2009. Wallen F, Kelly Smith et al. Impact of hospital type on surgical treatment for kidney cancer: recent trends. Journal of urology. Elsevier, 2007 GJ DeCastro, JM McKiernon, Epidemiology and clinical staging and presentation of renal cell carcinoma. Urologic Clinics of North America. Elsevier, 2008 Woldrich, Mailin, Ritchie, Carrol et al. Sex differences in renal cell cancer presentation and survival. An analysis of the national cancer database 1993 – 2004. Vol 179 Issue 5 May 2008; pages 1709 - 1713 McKiernan JM, Teschendorf B, Katz J, Herr HW, Russo P. A comparison of hospital-based charges following partial and radical nephrectomy. Urol. Oncol. [Internet]. [cited 2013 Sep 12];71:3–6. Disponible en:: http://www.ncbi.nlm.nih.gov/pubmed/1247453 Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J. Urol. [Internet]. 1969 Mar [cited 2013 Dec 17];101(3):297–301. Available from: http://www.ncbi.nlm.nih.gov/pubmed/5765875 Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer [Internet]. 1971 Nov [cited 2013 Dec 17];28(5):1165–77. Available from: http://www.ncbi.nlm.nih.gov/pubmed/5125665 Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA. Cancer J. Clin. [Internet]. [cited 2013 Sep 12];612:69–90. Disponible en:: http://www.ncbi.nlm.nih.gov/pubmed/2129685 Jin F, Devesa SS, Chow WH, Zheng W, Ji BT, Fraumeni JF, et al. Cancer incidence trends in urban shanghai, 1972-1994: an update. Int. J. Cancer [Internet]. 1999 Nov 12 [cited 2013 Dec 17];83(4):435–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10508476 17. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur. J. Cancer [Internet]. 2010 Mar [cited 2013 Aug 8];464:765–81. Disponible en:: http://www.ncbi.nlm.nih.gov/pubmed/20116997 18. Varela R, Donoso W, Corredor H. Experiencia de nefrectomía radical en el Instituto Nacional de Cancerología. Bogotá, Colombia. Serie de casos. Urol. Colomb. [Internet]. 2010 [cited 2013 Oct 5];XIX2:39–44. Disponible en:: http://dialnet.unirioja.es/servlet/articulo?codigo=3423529 19. Thyavihally Y. Management of renal cell carcinoma with solitary metastasis. World J Urol [Internet]. 2005 [cited 2013 Aug 28];9:1–9. Disponible en:: http://www.biomedcentral.com/1477-7819/3/48 20. Beisland C, Medby PC, Beisland HO. Presumed radically treated renal cell carcinoma--recurrence of the disease and prognostic factors for subsequent survival. Scand. J. Urol. Nephrol. [Internet]. 2004 Jan;384:299–305. Disponible en:: http://www.ncbi.nlm.nih.gov/pubmed/15669589 21. Shekarriz B, Upadhyay J, Shekarriz H, de Assis Mendes Goes F, Bianco FJ, Tiguert R, et al. Comparison of costs and complications of radical and partial nephrectomy for treatment of localized renal cell carcinoma. Urology [Internet]. 2002 Feb [cited 2013 Sep 12];592:211–5. Disponible en:: http://www.ncbi.nlm.nih.gov/pubmed/11834387 22. Cairns P. Renal cell carcinoma. Cancer Biomark. [Internet]. 2010 Jan [cited 2013 Sep 12]; 91 - 6: 461 – 73. www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3308682&tool=pmcentrez&rendertype=abstract 23. Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J. Urol. [Internet]. 2006 Dec [cited 2013 Dec 17];176(6 Pt 1):2353–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17085101 24. Stafford HS, Saltzstein SL, Shimasaki S, Sanders C, Downs TM, Sadler GR. Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival. J. Urol. [Internet]. 2008 May [cited 2013 Dec 17];179(5):1704–8. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2677163&tool=pmcentrez&rendertype=abstract 25. Kümmerlin IPED, ten Kate FJW, Wijkstra H, de la Rosette JJMCH, Laguna MP. Changes in the stage and surgical management of renal tumours during 1995-2005: an analysis of the Dutch national histopathology registry. BJU Int. [Internet]. 2008 Oct [cited 2013 Dec 17];102(8):946–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18564136 26. Konnak JW, Grossman HB. Renal cell carcinoma as an incidental finding. J. Urol. [Internet]. 1985 Dec [cited 2013 Dec 17];134(6):1094–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/4057398 27. Thompson IM, Peek M. Improvement in survival of patients with renal cell carcinoma--the role of the serendipitously detected tumor. J. Urol. [Internet]. 1988 Sep [cited 2013 Dec 17];140(3):487–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3411657 28. Kessler O, Mukamel E, Hadar H, Gillon G, Konechezky M, Servadio C. Effect of improved diagnosis of renal cell carcinoma on the course of the disease. J. Surg. Oncol. [Internet]. 1994 Nov [cited 2013 Dec 17];57(3):201–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7967611 29. Parsons JK, Schoenberg MS, Carter HB. Incidental renal tumors: casting doubt on the efficacy of early intervention. Urology [Internet]. 2001 Jun [cited 2013 Dec 17];57(6):1013–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11377295 30. Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer [Internet]. 2008 Jul 1 [cited 2013 Dec 17];113(1):78–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18491376 31. Hock LM, Lynch J, Balaji KC. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J. Urol. [Internet]. 2002 Jan [cited 2013 Dec 17];167(1):57–60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11743275 32. Wallen EM, Pruthi RS, Joyce GF, Wise M. Kidney cancer. J. Urol. [Internet]. 2007 Jun [cited 2013 Dec 17];177(6):2006–18; discussion 2018–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17509280 33. Decastro GJ, McKiernan JM. Epidemiology, clinical staging, and presentation of renal cell carcinoma. Urol. Clin. North Am. [Internet]. 2008 Nov [cited 2013 Dec 17];35(4):581–92; vi. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18992612 34. Sanders PW. Pathogenesis and treatment of myeloma kidney. J. Lab. Clin. Med. [Internet]. 1994 Oct [cited 2013 Dec 17];124(4):484–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7930873 35. Sufrin G, Chasan S, Golio A, Murphy GP. Paraneoplastic and serologic syndromes of renal adenocarcinoma. Semin. Urol. [Internet]. 1989 Aug [cited 2013 Dec 17];7(3):158–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2690260 36. Gold PJ, Fefer A, Thompson JA. Paraneoplastic manifestations of renal cell carcinoma. Semin. Urol. Oncol. [Internet]. 1996 Nov [cited 2013 Dec 17];14(4):216–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8946620 37. Moein MR, Dehghani VO. Hypertension: a rare presentation of renal cell carcinoma. J. Urol. [Internet]. 2000 Dec [cited 2013 Dec 17];164(6):2019. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11061907 38. Wiesener MS, Seyfarth M, Warnecke C, Jürgensen JS, Rosenberger C, Morgan N V, et al. Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma. Blood [Internet]. 2002 May 15 [cited 2013 Dec 17];99(10):3562–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11986208 39. Kamra D, Boselli J, Sloane BB, Gladstone DE. Renal cell carcinoma induced Coombs negative autoimmune hemolytic anemia and severe thrombocytopenia responsive to nephrectomy. J. Urol. [Internet]. 2002 Mar [cited 2013 Dec 17];167(3):1395. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11832746 40. Hagel C, Stavrou D, Hansen HC. Paraneoplastic frontal lobe disorder and ataxia in renal cell carcinoma. Neuropathol. Appl. Neurobiol. [Internet]. 2005 Feb [cited 2013 Dec 17];31(1):97–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15634236 41. Costanzi S, Zoli A, Ferraro PM, Danza FM, Ferraccioli GF. A paraneoplastic retroperitoneal fibrosis resistant to corticosteroids treated with tamoxifen. Clin. Nephrol. [Internet]. 2008 Aug [cited 2013 Dec 17];70(2):172–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18793535 42. Moazzam M, Ather MH, Hussainy AS. Leiomyosarcoma presenting as a spontaneously ruptured renal tumor-case report. BMC Urol. [Internet]. 2002 Nov 19 [cited 2013 Dec 17];2:13. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=138801&tool=pmcentrez&rendertype=abstract 43. Elias AN. New-onset insulinopenic diabetes mellitus in a patient with an incidentally discovered renal cell carcinoma. Am. J. Med. [Internet]. 2005 Sep [cited 2013 Dec 17];118(9):1047–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16164894 44. Khatri V, Asensio J. Operative surgery manual [Internet]. 2003 [cited 2013 Oct 8]. Disponible en:: http://www.lavoisier.fr/livre/notice.asp?ouvrage=1517546 45. Batata M, Grabstald H. Upper urinary tract urothelial tumors. Urol Clin North Am. 1976;3:79–86. 46. Herr H. Long-term results of BCG therapy: concern about upper tract tumors. Semin Urol Oncol. 1998;16:13–6. 47. Lane B, Campbell S, Poggio E, Al. E. Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care. J Urol. 2009;182:4335–444. 48. Rini B, Campbell S, Escudier B. Renal cell carcinoma. Lancet. 2009;373:1119–32. 49. Fuhrman S, Lasky L, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;7:655–63. 50. Dall’Oglio MF, Arap MA, Antunes AA, Cury J, Leite KR, Srougi M. Impact of clinicopathological parameters in patients treated for renal cell carcinoma. J. Urol. [Internet]. 2007 May [cited 2013 Aug 28];1775:1687–91. Disponible en:: http://www.ncbi.nlm.nih.gov/pubmed/17437783 51. Sánchez Zalabardo D, Arocena García-Tapia J, Regojo Balboa JM, Fernández Montero JM, López Ferrandis J, Rosell Costa D, et al. Factores pronóstico en carcinoma renal pT3. Actas Urol. Esp. [Internet]. Elsevier España S. L.; 2003 Jan [cited 2013 Oct 28];271:26–32. Disponible en:: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0210-48062003000100006&lng=es&nrm=iso&tlng=e 52. Lacombe M. Renal arteriovenous fistula following nephrectomy. Urology [Internet]. 1985 Jan [cited 2014 Jan 22];25(1):13–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3966275 53. Okamoto M, Hashimoto M, Akita T, Sueda T, Karakawa S, Ohishi Y, et al. Congestive heart failure caused by aortocaval fistula after nephrectomy. Intern. Med. [Internet]. 2001 Nov [cited 2014 Jan 22];40(11):1113–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11757766 54. Escobar F, Gaviria F, Castellanos R, Aristizabal J, Arbélaez S, Bonilla A, et al. Nefrectomia radical laparoscópica. Análisis de una serie de casos. Rev. Urol. Colomb. [Internet]. Sociedad Colombiana de Urología; 2005 55. Castillo C O, Sánchez-Salas R, Vidal M I, Vitagliano G, Díaz C M, Fonerón V A, et al. Complicaciones en nefrectomía parcial laparoscópica por tumores renales: análisis de 147 pacientes operados en forma consecutiva. Rev. Chil. cirugía [Internet]. Sociedad de Cirujanos de Chile; 2008 Jun [cited 2013 Nov 14];603:219–25. Disponible en:: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-40262008000300009&lng=es&nrm=iso&tlng=es 56. L MK, G RO. Nefrectomía radical laparoscópica en el tratamiento del carcinoma de células renales: análisis de los primeros 50 casos. Rev Chil Urol [Internet]. 2006 [cited 2013 Nov 14]; Disponible en:: http://www.revistacirugia.cl/PDF Cirujanos 2006_02/Cir.22006.09.pdf 57. Bazán A, González S. Análisis comparativo de la nefrectomía parcial abierta versus laparoscópica en el tratamiento del tumor renal. Rev Arg Urol [Internet]. 2013 [cited 2013 Nov 14]; Disponible en:: http://www.revistasau.org/index.php/revista/article/viewFile/3369/3282 58. Husillos Alonso A, Subirá Ríos D, López López E, Ogaya Piniés G, Piñero Sánchez Ja, Aragón Chamizo J, et al. Resección laparoscópica pura de la recurrencia local del cáncer renal tras nefrectomía con intención curativa: análisis de la técnica quirúrgica y seguimiento oncológico de una serie de 8 casos. LXXVII Congr. Nac. Urol. 2012 59. Tolosa Eizaguirre E, Pascual Piédrola I, Barba Abad JF, Rincón Mayans A, Romero Vargas LM, Zudaire JJ. Nefrectomía parcial laparoscópica.: Análisis de los primeros 30 casos de nuestra serie y revisión de la literatura [Internet]. Actas urológicas españolas Organo Of. difusión la Asoc. Española Urol. Ene; 2010 [cited 2013 Nov 14]. p. 798–801. Disponible en:: http://dialnet.unirioja.es/servlet/articulo?codigo=3278159&info=resumen&idioma=SPA Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur. J. Cancer [Internet]. 2010 Mar [cited 2013 Aug 8];464:765–81. Disponible en:: http://www.ncbi.nlm.nih.gov/pubmed/20116997 Varela R, Donoso W, Corredor H. Experiencia de nefrectomía radical en el Instituto Nacional de Cancerología. Bogotá, Colombia. Serie de casos. Urol. Colomb. [Internet]. 2010 [cited 2013 Oct 5];XIX2:39–44. Disponible en:: http://dialnet.unirioja.es/servlet/articulo?codigo=3423529 Thyavihally Y. Management of renal cell carcinoma with solitary metastasis. World J Urol [Internet]. 2005 [cited 2013 Aug 28];9:1–9. Disponible en:: http://www.biomedcentral.com/1477-7819/3/48 Beisland C, Medby PC, Beisland HO. Presumed radically treated renal cell carcinoma--recurrence of the disease and prognostic factors for subsequent survival. Scand. J. Urol. Nephrol. [Internet]. 2004 Jan;384:299–305. Disponible en:: http://www.ncbi.nlm.nih.gov/pubmed/15669589 Shekarriz B, Upadhyay J, Shekarriz H, de Assis Mendes Goes F, Bianco FJ, Tiguert R, et al. Comparison of costs and complications of radical and partial nephrectomy for treatment of localized renal cell carcinoma. Urology [Internet]. 2002 Feb [cited 2013 Sep 12];592:211–5. Disponible en:: http://www.ncbi.nlm.nih.gov/pubmed/11834387 Cairns P. Renal cell carcinoma. Cancer Biomark. [Internet]. 2010 Jan [cited 2013 Sep 12]; 91 - 6: 461 – 73. www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3308682&tool=pmcentrez&rendertype=abstract Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J. Urol. [Internet]. 2006 Dec [cited 2013 Dec 17];176(6 Pt 1):2353–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17085101 Stafford HS, Saltzstein SL, Shimasaki S, Sanders C, Downs TM, Sadler GR. Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival. J. Urol. [Internet]. 2008 May [cited 2013 Dec 17];179(5):1704–8. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2677163&tool=pmcentrez&rendertype=abstract Kümmerlin IPED, ten Kate FJW, Wijkstra H, de la Rosette JJMCH, Laguna MP. Changes in the stage and surgical management of renal tumours during 1995-2005: an analysis of the Dutch national histopathology registry. BJU Int. [Internet]. 2008 Oct [cited 2013 Dec 17];102(8):946–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18564136 Konnak JW, Grossman HB. Renal cell carcinoma as an incidental finding. J. Urol. [Internet]. 1985 Dec [cited 2013 Dec 17];134(6):1094–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/4057398 Thompson IM, Peek M. Improvement in survival of patients with renal cell carcinoma--the role of the serendipitously detected tumor. J. Urol. [Internet]. 1988 Sep [cited 2013 Dec 17];140(3):487–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3411657 Kessler O, Mukamel E, Hadar H, Gillon G, Konechezky M, Servadio C. Effect of improved diagnosis of renal cell carcinoma on the course of the disease. J. Surg. Oncol. [Internet]. 1994 Nov [cited 2013 Dec 17];57(3):201–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7967611 Parsons JK, Schoenberg MS, Carter HB. Incidental renal tumors: casting doubt on the efficacy of early intervention. Urology [Internet]. 2001 Jun [cited 2013 Dec 17];57(6):1013–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11377295 Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer [Internet]. 2008 Jul 1 [cited 2013 Dec 17];113(1):78–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18491376 Hock LM, Lynch J, Balaji KC. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J. Urol. [Internet]. 2002 Jan [cited 2013 Dec 17];167(1):57–60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11743275 Wallen EM, Pruthi RS, Joyce GF, Wise M. Kidney cancer. J. Urol. [Internet]. 2007 Jun [cited 2013 Dec 17];177(6):2006–18; discussion 2018–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17509280 Decastro GJ, McKiernan JM. Epidemiology, clinical staging, and presentation of renal cell carcinoma. Urol. Clin. North Am. [Internet]. 2008 Nov [cited 2013 Dec 17];35(4):581–92; vi. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18992612 Sanders PW. Pathogenesis and treatment of myeloma kidney. J. Lab. Clin. Med. [Internet]. 1994 Oct [cited 2013 Dec 17];124(4):484–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7930873 Sufrin G, Chasan S, Golio A, Murphy GP. Paraneoplastic and serologic syndromes of renal adenocarcinoma. Semin. Urol. [Internet]. 1989 Aug [cited 2013 Dec 17];7(3):158–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2690260 Gold PJ, Fefer A, Thompson JA. Paraneoplastic manifestations of renal cell carcinoma. Semin. Urol. Oncol. [Internet]. 1996 Nov [cited 2013 Dec 17];14(4):216–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8946620 Moein MR, Dehghani VO. Hypertension: a rare presentation of renal cell carcinoma. J. Urol. [Internet]. 2000 Dec [cited 2013 Dec 17];164(6):2019. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11061907 Wiesener MS, Seyfarth M, Warnecke C, Jürgensen JS, Rosenberger C, Morgan N V, et al. Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma. Blood [Internet]. 2002 May 15 [cited 2013 Dec 17];99(10):3562–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11986208 Kamra D, Boselli J, Sloane BB, Gladstone DE. Renal cell carcinoma induced Coombs negative autoimmune hemolytic anemia and severe thrombocytopenia responsive to nephrectomy. J. Urol. [Internet]. 2002 Mar [cited 2013 Dec 17];167(3):1395. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11832746 Hagel C, Stavrou D, Hansen HC. Paraneoplastic frontal lobe disorder and ataxia in renal cell carcinoma. Neuropathol. Appl. Neurobiol. [Internet]. 2005 Feb [cited 2013 Dec 17];31(1):97–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15634236 Costanzi S, Zoli A, Ferraro PM, Danza FM, Ferraccioli GF. A paraneoplastic retroperitoneal fibrosis resistant to corticosteroids treated with tamoxifen. Clin. Nephrol. [Internet]. 2008 Aug [cited 2013 Dec 17];70(2):172–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18793535 Moazzam M, Ather MH, Hussainy AS. Leiomyosarcoma presenting as a spontaneously ruptured renal tumor-case report. BMC Urol. [Internet]. 2002 Nov 19 [cited 2013 Dec 17];2:13. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=138801&tool=pmcentrez&rendertype=abstract Elias AN. New-onset insulinopenic diabetes mellitus in a patient with an incidentally discovered renal cell carcinoma. Am. J. Med. [Internet]. 2005 Sep [cited 2013 Dec 17];118(9):1047–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16164894 Khatri V, Asensio J. Operative surgery manual [Internet]. 2003 [cited 2013 Oct 8]. Disponible en:: http://www.lavoisier.fr/livre/notice.asp?ouvrage=1517546 Batata M, Grabstald H. Upper urinary tract urothelial tumors. Urol Clin North Am. 1976;3:79–86. Herr H. Long-term results of BCG therapy: concern about upper tract tumors. Semin Urol Oncol. 1998;16:13–6. Lane B, Campbell S, Poggio E, Al. E. Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care. J Urol. 2009;182:4335–444. Rini B, Campbell S, Escudier B. Renal cell carcinoma. Lancet. 2009;373:1119–32. Fuhrman S, Lasky L, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;7:655–63. Dall’Oglio MF, Arap MA, Antunes AA, Cury J, Leite KR, Srougi M. Impact of clinicopathological parameters in patients treated for renal cell carcinoma. J. Urol. [Internet]. 2007 May [cited 2013 Aug 28];1775:1687–91. Disponible en:: http://www.ncbi.nlm.nih.gov/pubmed/17437783 Sánchez Zalabardo D, Arocena García-Tapia J, Regojo Balboa JM, Fernández Montero JM, López Ferrandis J, Rosell Costa D, et al. Factores pronóstico en carcinoma renal pT3. Actas Urol. Esp. [Internet]. Elsevier España S. L.; 2003 Jan [cited 2013 Oct 28];271:26–32. Disponible en:: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0210-48062003000100006&lng=es&nrm=iso&tlng=e Lacombe M. Renal arteriovenous fistula following nephrectomy. Urology [Internet]. 1985 Jan [cited 2014 Jan 22];25(1):13–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3966275 Okamoto M, Hashimoto M, Akita T, Sueda T, Karakawa S, Ohishi Y, et al. Congestive heart failure caused by aortocaval fistula after nephrectomy. Intern. Med. [Internet]. 2001 Nov [cited 2014 Jan 22];40(11):1113–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11757766 Escobar F, Gaviria F, Castellanos R, Aristizabal J, Arbélaez S, Bonilla A, et al. Nefrectomia radical laparoscópica. Análisis de una serie de casos. Rev. Urol. Colomb. [Internet]. Sociedad Colombiana de Urología; 2005 Castillo C O, Sánchez-Salas R, Vidal M I, Vitagliano G, Díaz C M, Fonerón V A, et al. Complicaciones en nefrectomía parcial laparoscópica por tumores renales: análisis de 147 pacientes operados en forma consecutiva. Rev. Chil. cirugía [Internet]. Sociedad de Cirujanos de Chile; 2008 Jun [cited 2013 Nov 14];603:219–25. Disponible en:: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-40262008000300009&lng=es&nrm=iso&tlng=es L MK, G RO. Nefrectomía radical laparoscópica en el tratamiento del carcinoma de células renales: análisis de los primeros 50 casos. Rev Chil Urol [Internet]. 2006 [cited 2013 Nov 14]; Disponible en:: http://www.revistacirugia.cl/PDF Cirujanos 2006_02/Cir.22006.09.pdf Bazán A, González S. Análisis comparativo de la nefrectomía parcial abierta versus laparoscópica en el tratamiento del tumor renal. Rev Arg Urol [Internet]. 2013 [cited 2013 Nov 14]; Disponible en:: http://www.revistasau.org/index.php/revista/article/viewFile/3369/3282 Husillos Alonso A, Subirá Ríos D, López López E, Ogaya Piniés G, Piñero Sánchez Ja, Aragón Chamizo J, et al. Resección laparoscópica pura de la recurrencia local del cáncer renal tras nefrectomía con intención curativa: análisis de la técnica quirúrgica y seguimiento oncológico de una serie de 8 casos. LXXVII Congr. Nac. Urol. 2012 Tolosa Eizaguirre E, Pascual Piédrola I, Barba Abad JF, Rincón Mayans A, Romero Vargas LM, Zudaire JJ. Nefrectomía parcial laparoscópica.: Análisis de los primeros 30 casos de nuestra serie y revisión de la literatura [Internet]. Actas urológicas españolas Organo Of. difusión la Asoc. Española Urol. Ene; 2010 [cited 2013 Nov 14]. p. 798–801. Disponible en:: http://dialnet.unirioja.es/servlet/articulo?codigo=3278159&info=resumen&idioma=SPA |
| Palavras-Chave | #NEFRECTOMÍA #nephrectomy |
| Tipo |
info:eu-repo/semantics/bachelorThesis info:eu-repo/semantics/submittedVersion |
